In vitro reconstitution of the human RISC-loading complex

Proceedings of the National Academy of Sciences of the United States of America
Ian J MacRaeJennifer A Doudna

Abstract

Targeted gene silencing by RNAi requires the RNA-induced silencing complex (RISC), whose core component is the protein Argonaute (Ago) bound to a microRNA (miRNA) or an siRNA. In humans, Ago2 is loaded with miRNAs by the action of a specialized assembly called the RISC-loading complex (RLC), comprising the proteins Ago2, Dicer, and TRBP. Here we show that the human RLC assembles spontaneously in vitro from purified components. No cofactors or chaperones are required for the complex to form. The reconstituted RLC, containing one copy of each protein, has the dicing, slicing, guide-strand selection, and Ago2-loading activities observed for the endogenous RLC. Furthermore, once Ago2 is loaded with an miRNA, it tends to dissociate from the rest of the complex. These results lay the groundwork for future structural and functional dissection of RISC loading in humans.

References

Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·G P CosentinoN Sonenberg
Mar 27, 2002·Genes & Development·Zissimos MourelatosGideon Dreyfuss
Aug 9, 2003·Genomics·Takashi SasakiNobuyoshi Shimizu
Sep 26, 2003·Nature·Amy A CaudyRonald H A Plasterk
Oct 22, 2003·Cell·Dianne S SchwarzPhillip D Zamore
Oct 22, 2003·Cell·Anastasia KhvorovaSumedha D Jayasena
Mar 24, 2004·Cell·Yukihide TomariPhillip D Zamore
Jul 10, 2004·Cell·Haidi ZhangWitold Filipowicz
Apr 1, 2005·Nature Structural & Molecular Biology·Fabiola V RivasLeemor Joshua-Tor
Jun 24, 2005·Nature·Thimmaiah P ChendrimadaRamin Shiekhattar
Jul 13, 2005·Cell·Witold Filipowicz
Nov 8, 2005·Cell·Richard I GregoryRamin Shiekhattar
Nov 15, 2005·Nature Cell Biology·Jidong LiuGregory J Hannon
Nov 18, 2005·Current Biology : CB·Gunter MeisterThomas Tuschl
Dec 17, 2005·Genes & Development·Elisavet Maniataki, Zissimos Mourelatos
Jan 21, 2006·The EMBO Journal·Yoontae LeeV Narry Kim
Jun 24, 2006·Chemistry & Biology·Justin L P BeneschCarol V Robinson
Aug 31, 2006·Journal of the American Chemical Society·Adam R McKayCarol V Robinson
Mar 27, 2007·Cell·Shobha Vasudevan, Joan A Steitz
May 29, 2007·Molecular Cell·G Brett Robb, Tariq M Rana
Jun 15, 2007·Molecular Cell·Lasse Peters, Gunter Meister

❮ Previous
Next ❯

Citations

May 25, 2011·Cellular and Molecular Life Sciences : CMLS·Julia Starega-RoslanWlodzimierz J Krzyzosiak
Jul 14, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Christopher R Sibley, Matthew J A Wood
Apr 2, 2013·Trends in Biochemical Sciences·Claus-D Kuhn, Leemor Joshua-Tor
Feb 27, 2010·Biochemistry·Joseph A GredellS Patrick Walton
Aug 13, 2011·The Journal of Organic Chemistry·Hayden PeacockCynthia J Burrows
Mar 4, 2009·Nature Cell Biology·Julia WinterSven Diederichs
Jan 24, 2009·Nature Reviews. Molecular Cell Biology·V Narry KimMikiko C Siomi
Oct 13, 2009·Nature Structural & Molecular Biology·Hong-Wei WangEva Nogales
Dec 8, 2009·Nature Structural & Molecular Biology·Mayuko YodaYukihide Tomari
May 10, 2011·Nature Structural & Molecular Biology·Xuecheng YeHong Zhang
Mar 20, 2012·Nature Structural & Molecular Biology·Pick-Wei LauIan J MacRae
Apr 10, 2012·Nature Structural & Molecular Biology·Derrick GibbingsOlivier Voinnet
Apr 30, 2013·Nature Structural & Molecular Biology·David W TaylorHong-Wei Wang
May 22, 2009·Molecular Biology of the Cell·Justin M PareTom C Hobman
Jun 10, 2008·Cardiovascular Research·Francesco Fazi, Clara Nervi
Mar 20, 2009·Human Molecular Genetics·Marc S Weinberg, Matthew J A Wood
Oct 18, 2008·Nucleic Acids Research·Harris S SoiferJohn J Rossi
Oct 8, 2009·Nucleic Acids Research·Grace S TanMarianthi Kiriakidou
Jan 22, 2011·Nucleic Acids Research·Kyoungho SukFrederick P Roth
Oct 26, 2010·Nucleic Acids Research·Kumi SakuraiJohn J Rossi
Jul 20, 2012·Nucleic Acids Research·Anne DallasBrian H Johnston
Feb 26, 2013·Nucleic Acids Research·Matthieu P M H BenoitMichael J Plevin
May 11, 2013·Nucleic Acids Research·Ho Young LeeJennifer A Doudna
Sep 3, 2010·Cold Spring Harbor Perspectives in Biology·Leemor Joshua-Tor, Gregory J Hannon
Jun 3, 2011·Genes & Development·Alex S Flynt, Eric C Lai
Mar 14, 2012·Clinical and Experimental Pharmacology & Physiology·Chun LiMing Q Wei
Apr 16, 2010·Journal of Virology·Isabelle PelletierFlorence Colbère-Garapin
Aug 31, 2012·Microbiology and Molecular Biology Reviews : MMBR·Sylvanne M Daniels, Anne Gatignol
Mar 9, 2010·Annual Review of Biochemistry·Qinghua Liu, Zain Paroo
May 9, 2009·BMC Molecular Biology·Sylvanne M DanielsAnne Gatignol
May 3, 2011·BMC Molecular Biology·Grace S TanMarianthi Kiriakidou
Feb 11, 2011·BMC Molecular Biology·Yoshinari AndoYoshihide Hayashizaki
Aug 12, 2009·Cell Communication and Signaling : CCS·Brandi N Davis, Akiko Hata
Nov 23, 2011·RNA·Juan G Betancur, Yukihide Tomari
Sep 26, 2012·RNA·Ho Young Lee, Jennifer A Doudna
Mar 28, 2013·RNA·Cameron L Noland, Jennifer A Doudna
Oct 12, 2010·RNA·Alessandra MescalchinGeorg Sczakiel
Sep 20, 2008·PLoS Computational Biology·Wallace F Marshall

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPRi Screens for Antibiotics

The CRISPR-Cas system is a gene editing technique that can be used for high-throughput genome-wide screens to identify modes of actions of novel antibiotics. Here is the latest research.

BioHub - Researcher Network

The Chan-Zuckerberg Biohub aims to support the fundamental research and develop the technologies that will enable physicians to cure, prevent, or manage all diseases in our childrens' lifetimes. The CZ Biohub brings together researchers from UC Berkeley, Stanford, and UCSF. Find the latest research from the CZ Biohub researcher network here.

Biophysics of CRISPR

This feed focuses on broad characteristics of the CRISPR system and the proteins associated with it.